(i) The complexity of the pathology makes it difficult to be compliant with the CPG
96
61 (63.5)
11 (11.5)
24 (25.0)
(ii) The risk of hypoglycemia continues to be a limiting factor for the comprehensive control of patients with diabetes
96
12 (12.5)
4 (4.2)
80 (83.4)†
Clinician-related factors
(i) Therapeutic inertia means that despite knowing the CPG recommendations, the clinician continues with his previous practice
96
12 (12.5)
4 (4.2)
80 (83.3)†
(ii) The constant updates of the CPGs make it difficult to be up to date and have a deep knowledge of them
96
28 (29.2)
8 (8.3)
60 (62.5)
(iii) Professionals must handle complex pharmacological treatment, which is perceived as a difficulty for intensification
96
24 (25.0)
12 (12.5)
60 (62.5)
(iv) The lack of connection between all the members of the interdisciplinary team that manages diabetes makes access to new agents and combined therapies difficult
96
23 (23.9)
10 (10.4)
63 (65.6)
(v) It would be necessary to have the support of dietitians and podiatrists in the management of patients with T2DM
98
1 (1.0)
3 (3.1)
94 (95.9)
(vi) The insufficient number of nursing personnel with specific training in diabetes education makes it difficult to approach patients with T2DM
98
2 (2.0)
2 (2.0)
94 (95.9)
Consensus achieved in the first Delphi round; †consensus achieved in the second Delphi round.
